Form 8-K - Current report:
SEC Accession No. 0001213900-25-026322
Filing Date
2025-03-31
Accepted
2025-03-31 16:39:31
Documents
14
Period of Report
2025-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0236436-8k_ostherapi.htm   iXBRL 8-K 27692
2 PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON MARCH 31, 2025 ea023643601ex99-1_ostherapi.htm EX-99.1 25323
  Complete submission text file 0001213900-25-026322.txt   235444

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ostx-20250331.xsd EX-101.SCH 3023
4 XBRL LABEL FILE ostx-20250331_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE ostx-20250331_pre.xml EX-101.PRE 22364
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0236436-8k_ostherapi_htm.xml XML 3811
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42195 | Film No.: 25794061
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)